https://newzino.com/story/replimune-rp1-melanoma-review Newzino en 2026-07-30T11:11:14+00:00 FDA weighs Replimune's melanoma immunotherapy RP1 https://newzino.com/story/nro-space-reconnaissance-buildout Newzino en 2026-07-30T11:08:07+00:00 US spy agency builds the largest satellite network in history https://newzino.com/story/silver-diamine-fluoride-drill-free-cavity-care Newzino en 2026-07-30T03:09:12+00:00 US trial backs drill-free liquid that stops childhood cavities https://newzino.com/story/ai-research-publishing-gap Newzino en 2026-07-30T00:28:39+00:00 Study finds most billion-dollar AI startups rarely publish research https://newzino.com/story/paducah-doe-data-center-power-campus Newzino en 2026-07-29T18:08:41+00:00 Coalition to build data center and dedicated power campus at DOE's Paducah site https://newzino.com/story/grant-thornton-cbiz-acquisition Newzino en 2026-07-29T18:05:51+00:00 Grant Thornton buys CBIZ in $5 billion cash deal https://newzino.com/story/ford-2026-margin-expansion-guidance-raise Newzino en 2026-07-29T03:09:51+00:00 Ford lifts 2026 profit outlook as margins climb through an aluminum crunch https://newzino.com/story/ensitrelvir-oral-covid-prevention Newzino en 2026-07-29T03:06:56+00:00 Oral drug to prevent COVID-19 after exposure reaches US market https://newzino.com/story/china-private-economy-policy Newzino en 2026-07-29T02:04:01+00:00 China passes its first law dedicated to the private economy